Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.

Br J Cancer · 2025 · PMC12322073 · PMID 40382522

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

borderline significantp = 0.057so close (0.05 < p ≤ 0.1)

For PFS, treatment with platinum/etoposide was significantly inferior and PS borderline significant ( p = 0.057).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.